Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dario Health Corp (DRIO)

Dario Health Corp (DRIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 230,658
  • Shares Outstanding, K 15,543
  • Annual Sales, $ 7,580 K
  • Annual Income, $ -29,450 K
  • 60-Month Beta 1.34
  • Price/Sales 29.99
  • Price/Cash Flow N/A
  • Price/Book 2.02
Trade DRIO with:

Options Overview

Details
  • Implied Volatility 94.71%
  • Historical Volatility 59.19%
  • IV Percentile 25%
  • IV Rank 13.55%
  • IV High 172.70% on 03/30/21
  • IV Low 82.49% on 07/21/21
  • Put/Call Vol Ratio 0.50
  • Today's Volume 6
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 2,183
  • Open Int (30-Day) 2,522

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.84
  • Number of Estimates 2
  • High Estimate -0.69
  • Low Estimate -0.98
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -25.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.16 +4.31%
on 07/30/21
21.00 -29.67%
on 07/12/21
-5.89 (-28.51%)
since 07/02/21
3-Month
13.78 +7.18%
on 05/13/21
23.80 -37.94%
on 06/24/21
-6.91 (-31.87%)
since 04/30/21
52-Week
10.01 +47.55%
on 10/30/20
31.85 -53.63%
on 02/16/21
+2.37 (+19.11%)
since 07/31/20

Most Recent Stories

More News
DarioHealth Launches Behavioral Health Solutions Globally in New Partnership with Workplace Options

/PRNewswire/ -- DarioHealth Corp. (: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that now includes Workplace Options...

DRIO : 14.77 (-0.47%)
DarioHealth Chosen to Provide Remote Patient Monitoring for Alabama Regional Medical Services

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services...

DRIO : 14.77 (-0.47%)
DarioHealth Chief Medical Officer Omar Manejwala, M.D., to Present on the Role of Digital Therapeutics in Post-Pandemic Healthcare at DTx Europe

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer , M.D. will present "Rebalancing: Digital Therapeutics in a Post-Pandemic...

DRIO : 14.77 (-0.47%)
DarioHealth Expands Employer Footprint with Three New Contracts

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced the launch of three new employer client contracts, including one global partnership,...

DRIO : 14.77 (-0.47%)
New Research from DarioHealth Expands Evidence that Personalized Interventions Impact Health Behaviors and Improve User Engagement

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, presented new clinical research today at the American Diabetes Association (ADA) 81 Scientific...

DRIO : 14.77 (-0.47%)
DarioHealth Remote Patient Monitoring Selected by Coastal Family Health Center to Improve Health of Patients with Hypertension

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as digital health provider by Coastal Family Health Center, a...

DRIO : 14.77 (-0.47%)
DarioHealth Expands Footprint in Musculoskeletal Sensor Technologies with the Upright GO S

/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of the Upright GO S, a new wearable sensor based on the company's...

DRIO : 14.77 (-0.47%)
DarioHealth to be Added to Russell 2000® and 3000® Indexes

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market 3000 Index and the small-cap 2000 Index at the...

DRIO : 14.77 (-0.47%)
DarioHealth Announces Closing of wayForward Acquisition

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the consummation of the previously announced acquisition of PsyInnovations,...

DRIO : 14.77 (-0.47%)
DarioHealth Releases Study Demonstrating the Impact of Personalized Digital Interventions to Improve Self-Management of Diabetes

, /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it will be presenting results of a new study at the 14th International Conference...

DRIO : 14.77 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors...

See More

Key Turning Points

3rd Resistance Point 16.31
2nd Resistance Point 15.92
1st Resistance Point 15.34
Last Price 14.77
1st Support Level 14.37
2nd Support Level 13.98
3rd Support Level 13.40

See More

52-Week High 31.85
Fibonacci 61.8% 23.51
Fibonacci 50% 20.93
Fibonacci 38.2% 18.35
Last Price 14.77
52-Week Low 10.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar